PPA Research Group, Inc. is dedicated to speeding up the therapeutic drug discovery development and immunotherapy studies by providing the highest quality of human hematologic products from fresh hematologic tissues to isolated hematopoietic primary cells from healthy and diseased donors.

PPA Research Group not only has its own tissue collection sites but also the largest nationwide hematologic tissue collection network with the largest repository of donor profiles in the nation. PPA Research Group is specialized in the area of hematology and immunology. We offer a broad range of human hematologic products from Leukopaks, bone marrows, to most types of human hematopoietic primary cells. Our signature products are human diseased Leukopaks. These products have been used in preclinical aspects of drug discovery such as target discovery, validation, lead optimization, and toxicity assays.

PPA Research Group is fully certified in accordance with Local, State and Federal business requirements. We participate in an Institute Review Board (IRB) or Human Subject Committee approved donor program, and each normal adult volunteer is screened for general health, including tests for HIV, hepatitis B, and hepatitis C.

Our experience in preparing and shipping products ensures you of the highest quality human primary cells and subcellular fractions for your research. We also ship fresh products throughout North America and to worldwide.

We offer customized products including special collection conditions, donor demographic selections, customized aliquots, repeat donors, small and large-scale cell isolation, special shipping conditions, etc. PPA Research Group’ technical support team provides pre- and post-sales support. Our products are delivered in a timely manner and ready to use. We offer an unconditional product guarantee.

Our commitment to providing you the best quality, service and support is our top priority. Our quality assurance includes:

  • QA/QC of products
  • Document control and tracking
  • Archives
  • Calibration of equipment
  • Adherence to SOPs
  • Enforcement of PPA Research Group’ Quality Policy